The Effectiveness of BreatheMAX Breathing Device on Secretion Clearance (ESMOSC)

Khon Kaen University

Status and phase: Unknown; Phase 3; Phase 2

Conditions: Lung Disease

Treatments: Device: BreatheMAX breathing device

Study type: Interventional

Funder types: Other

Identifiers

NCT01090804

47660279

Details and patient eligibility

About

The purpose of this study is to determined effects of BreatheMAX on secretion clearance.

Enrollment: 14 estimated patients

Sex: All

Ages: 15 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• One sign of secretion accumulation in bronchi
• Stable cardiopulmonary function
• Good consciousness and good co-operation

Exclusion criteria

• Massive hemoptysis
• Pneumothorax (untreated)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

14 participants in 1 patient group

breathing exercise

Experimental group

Description:

BreatheMAX breathing device is Water pressure Threshold Bottle. The level of water in the cylinder determines the load for treatment. In the treatment using 20% PNIP (Peak negative inspiratory pressure) was performed with 6-10 breaths/set; 10 set/day

Treatment:

Device: BreatheMAX breathing device